Latest News

First-in-human patients continue to benefit from VenoValve at average of three...

Positive long-term, three-year observational data from a cohort of patients that participated in the previously concluded VenoValve (Envveno Medical) first-in-human clinical trial were recently...

From the Editor

An open letter to the National Rifle Association

Hello, I think it is time we talked about guns. I know you don’t like to discuss these things after a school shooting, so I...

No time like the present: The moral imperative for advocacy in...

“I’m so sorry but we have to cancel your surgery”—10 words any warm-blooded surgeon dreads uttering. This time around, it was not for the...

SVS news

Veterans Day: Remembering Korea, ‘accidental pioneers’ and M*A*S*H

During November—Nov. 11, specifically—the United States salutes and honors all those who have served this country in its armed forces. This November, the Society...

New diversity, equity and inclusion pillar signals additional priority for SVS...

The Society for Vascular Surgery (SVS) Foundation has been guided by the three long-term pillars of research and innovation, community vascular care and patient...

Commentary

I recently took the Registered Physician in Vascular Interpretation (RPVI) exam. While studying for it, one of the concepts that stood out was the signal-to-noise ratio (SNR) in vascular ultrasound, and how it accounted for the quality of images....

VAM news

The Society for Vascular Surgery (SVS) wants members’ research on vascular disease for the 2023 Vascular Research Initiatives Conference (VRIC) and the 2023 Vascular Annual Meeting (VAM). VRIC will be held Tuesday, May 10, 2023, at the Boston Marriott Copley...